Treatment | Month | Total number | Proportion | 95% CI | P-valuea |
---|---|---|---|---|---|
Control 1 | 2 | 30 | 100 | 92.3–100 | – |
3 | 27 | 51.85 | 33.99–69.26 | – | |
4 | 26 | 65.38 | 47.10–83.67 | – | |
5 | 13 | 69.23 | 44.14–94.32 | – | |
6 | 32 | 96.88 | 0.85–98.33 | – | |
8 | 31 | 90.32 | 75.10–96.65 | – | |
Control 2 | 2 | 32 | 75.00 | 53.78–96.22 | 0.04 |
3 | 44 | 88.64 | 79.26–98.01 | < 0.0001 | |
4 | 30 | 63.33 | 46.09–80.58 | 0.87 | |
5 | 25 | 92.00 | 75.03–97.78 | 0.07 | |
6 | 49 | 97.96 | 89.31–99.64 | 0.76 | |
8 | 26 | 57.69 | 38.70–76.68 | < 0.0001 | |
SumiShield 1 | 2 | 56 | 80.36 | 69.95–90.76 | 0.06 |
3 | 25 | 64.00 | 45.18–82.82 | 0.38 | |
4 | 35 | 48.57 | 32.01–65.13 | 0.19 | |
5 | 17 | 82.35 | 64.23–99.20 | 0.4 | |
6 | 27 | 88.89 | 77.03–96.30 | 0.22 | |
8 | 14 | 42.86 | 16.93–68.78 | < 0.0001 | |
SumiShield 2 | 2 | 27 | 51.85 | 33.99–69.26 | < 0.0001 |
3 | 12 | 33.33 | 6.66–60.01 | 0.28 | |
4 | 49 | 30.61 | 17.71–43.52 | < 0.0001 | |
5 | 24 | 70.83 | 52.65–89.02 | 0.92 | |
6 | 38 | 68.42 | 53.64–83.20 | < 0.0001 | |
8 | 22 | 90.91 | 72.19–97.47 | 0.94 | |
Deltamethrin 1 | 2 | 47 | 19.15 | 7.90–30.40 | < 0.0001 |
3 | 40 | 57.50 | 42.18–72.82 | 0.65 | |
4 | 32 | 53.13 | 35.83–70.42 | 0.35 | |
5 | 17 | 64.71 | 41.99–87.42 | 0.79 | |
6 | 13 | 38.46 | 12.01–64.91 | < 0.0001 | |
8 | 25 | 48.00 | 28.42–67.58 | < 0.0001 | |
Deltamethrin 2 | 2 | 21 | 9.52 | 3.03–22.08 | < 0.0001 |
3 | 18 | 16.67 | 0.55–33.88 | 0.02 | |
4 | 42 | 30.95 | 16.97–44.93 | 0.01 | |
5 | 19 | 15.79 | 0.61–32.19 | < 0.0001 | |
6 | 32 | 100 | 97.12–100 | 0.31 | |
8 | 22 | 9.09 | 1.53–21.10 | < 0.0001 |